Delta Opioid Receptor (DOR) Neurons

Delta Opioid Receptor (DOR) Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Delta Opioid Receptor (DOR) Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuropeptide receptor neurons</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>OPRM1 (for mu), OPRK1 (for kappa), OPRD1 (for delta)</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Delta Opioid Receptor (DOR)</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>G protein-coupled receptor (GPCR)</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>Endogenous: Enkephalins, β-endorphin; Exogenous: DADLE, DPDPE</td>
</tr>
<tr>
<td class="label">Primary Brain Regions</td>
<td>Limbic system, basal ganglia, brainstem, spinal cord</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0004124](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004124)</td>
<

Delta Opioid Receptor (DOR) Neurons

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Delta Opioid Receptor (DOR) Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuropeptide receptor neurons</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>OPRM1 (for mu), OPRK1 (for kappa), OPRD1 (for delta)</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Delta Opioid Receptor (DOR)</td>
</tr>
<tr>
<td class="label">Receptor Type</td>
<td>G protein-coupled receptor (GPCR)</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>Endogenous: Enkephalins, β-endorphin; Exogenous: DADLE, DPDPE</td>
</tr>
<tr>
<td class="label">Primary Brain Regions</td>
<td>Limbic system, basal ganglia, brainstem, spinal cord</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0004124](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0004124)</td>
</tr>
</table>

Delta Opioid Receptor (Dor) Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Delta opioid receptor (DOR) neurons are neurons that express the delta opioid receptor (also known as δ-opioid receptor or DOR), a G protein-coupled receptor that mediates the analgesic and rewarding effects of endogenous opioid peptides and exogenous opioid drugs. These neurons are distributed throughout the central and peripheral nervous systems and play critical roles in pain modulation, reward processing, mood regulation, and various autonomic functions. [@janak2013]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Molecular Biology

OPRD1 Gene

The OPRD1 gene (Opioid Receptor Delta 1) encodes the delta opioid receptor:

• Location: Chromosome 1p34.3 in humans
• Length: ~4.5 kb coding sequence
• Expression: Predominantly neuronal, some immune cell expression
• Isoforms: Multiple splice variants (DOR-1, DOR-2)

Receptor Structure

Delta opioid receptors are typical Class A GPCRs:

• Seven transmembrane domains: G protein-coupled structure
• N-terminal extracellular domain: Ligand binding
• C-terminal intracellular domain: G protein coupling
• Disulfide bond: Conserved cysteine pair
• Glycosylation sites: N-terminal modifications

Signal Transduction

DOR activation triggers multiple intracellular pathways:

• Reduced cAMP production
• Decreased neuronal excitability

• Activate inward-rectifier potassium channels
• Inhibit voltage-gated calcium channels
• Modulate MAPK pathways

• Receptor internalization
• MAPK activation
• Cell survival signals

Anatomy and Distribution

Brain Distribution

DOR neurons are found in:

Limbic System:

• Amygdala (central and basolateral nuclei)
• Hippocampus (CA1-CA3, dentate gyrus)
• Hypothalamus (paraventricular, arcuate nuclei)
• Bed nucleus of the stria terminalis

• Striatum (patch and matrix compartments)
• Nucleus accumbens (core and shell)
• Ventral pallidum
• Substantia nigra pars compacta

• Periaqueductal gray (PAG)
• Raphe nuclei
• Locus coeruleus
• Solitary nucleus

• Layer V pyramidal neurons
• Cortical interneurons

Spinal Cord

• Dorsal horn (laminae I-II): Primary pain transmission neurons
• Ventral horn: Motor neurons (indirect effects)
• Substantia gelatinosa: Nociceptive processing

Peripheral Nervous System

• Dorsal root ganglion (DRG) neurons
• Enteric nervous system
• Sympathetic ganglia

Physiology

Pain Modulation

DOR neurons play complex roles in pain processing:

Analgesic Effects:

• Suppress nociceptive transmission in dorsal horn
• Activate descending inhibitory pathways
• Reduce peripheral sensitization

• DOR agonists reduce chronic itching
• Different mechanisms from mu opioid receptors

• Acute: Analgesia
• Chronic: Tolerance development
• Paradoxical: Hyperalgesia in some contexts

Reward and Motivation

In the mesolimbic pathway:

• DOR activation enhances dopamine release in nucleus accumbens
• Reward reinforcement for natural rewards
• Conditioned place preference
• 介导介导 natural and drug rewards

Mood and Emotion

DOR in limbic structures affects:

• Anxiety: Anxiolytic effects of DOR agonists
• Depression: Antidepressant-like effects
• Emotional memory: Amygdala-dependent processes
• Social behavior: Modulation of social interactions

Autonomic Functions

• Respiratory regulation: Respiratory depression (milder than MOR)
• Gastrointestinal motility: Reduced transit
• Cardiovascular function: Blood pressure effects
• Thermoregulation: Body temperature modulation

Development

Ontogeny

DOR expression develops prenatally:

• Embryonic: Early expression in developing brain
• Perinatal: Significant expression in pain pathways
• Postnatal: Refinement of receptor distribution
• Aging: Changes in receptor density and function

Developmental Roles

DOR signaling participates in:

• Neuronal development: Differentiation and migration
• Synaptogenesis: Formation of pain pathways
• Circuit refinement: Activity-dependent sculpting

Disease Involvement

Alzheimer's Disease

DOR alterations in AD:

• DOR upregulation in hippocampus and cortex
• Cognitive effects: DOR agonists may impair memory
• Amyloid interaction: Aβ modulates DOR signaling
• Therapeutic targeting: DOR antagonists for cognitive enhancement
• Neuroprotection: DOR activation may have trophic effects

• Elevated DOR density in AD brains
• DOR blockade improves memory in animal models
• Interactions with cholinergic systems

Parkinson's Disease

In PD pathophysiology:

• Striatal DOR changes: Altered expression in basal ganglia
• Motor effects: DOR modulation of movement
• L-DOPA-induced dyskinesia: DOR involvement
• Neuroprotection: DOR agonist effects on dopaminergic neurons

Chronic Pain

DOR as a therapeutic target:

• Peripheral analgesia: DOR agonists effective in inflammatory pain
• Central mechanisms: Spinal and supraspinal sites
• Chronic neuropathic pain: Promising therapeutic target
• Side effect profile: Better than mu opioid agonists

Psychiatric Disorders

• Anxiety disorders: Anxiolytic potential
• Depression: Antidepressant effects in models
• Substance use disorders: Role in opioid reward
• Eating disorders: Modulation of feeding behavior

Epilepsy

• Seizure modulation: DOR agonists have anticonvulsant effects
• Neuroprotection: Reduced excitotoxicity
• Temporal lobe epilepsy: Altered DOR expression

Therapeutic Implications

Analgesic Development

Delta opioid receptor agonists offer advantages:

Drug Candidates

• DPDPE: Selective DOR agonist (research)
• DADLE: DOR agonist, shows neuroprotection
• SNC-80: Non-peptide DOR agonist
• ADL5859: DOR antagonist (cognitive effects)

Clinical Applications

• Chronic pain management
• Inflammatory conditions
• Psychiatric indications (anxiety, depression)
• Neuroprotective strategies

Side Effects

• Seizures (at high doses)
• Gastrointestinal effects
• Tolerance development
• Dysphoria (in some contexts)

Research Methods

Experimental Approaches

• Radioligand binding: Receptor quantification
• Immunohistochemistry: Protein localization
• In situ hybridization: mRNA distribution
• Electrophysiology: Neuronal responses
• Behavior: Pain, reward, mood assays

Genetic Models

• OPRD1 knockout mice: Loss of function studies
• Transgenic mice: Cell-type specific manipulations
• Conditional knockouts: Region-specific deletion
• Mu Opioid Receptor Neurons
• Kappa Opioid Receptor Neurons
• Opioid Signaling
• Pain Modulation
• Nociception
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Delta Opioid Receptor

Background

The study of Delta Opioid Receptor (Dor) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [NIH PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Literature search
• [IUPHAR Database](https://www.guidetopharmacology.org/) - Receptor pharmacology
• [Human Protein Atlas](https://www.proteinatlas.org/) - Expression data
• [OMIM OPRD1](https://omim.org/) - Genetic information

Pathway Diagram

The following diagram shows the key molecular relationships involving Delta Opioid Receptor (DOR) Neurons discovered through SciDEX knowledge graph analysis: